Based in the United States of America, Oncortarget is a peer-reviewed open access medical journal that talks about oncology. Oncology is simply a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. Its research is mainly on cancerous tumors, how to manage them and treat them if possible especially during the early stages. Oncology basically encompasses three components of dealing with cancer. One is prevention where a person is strictly advised to avoid the causative agents of cancer like tobacco. The second phase involves an early diagnosis of the abnormal growth. This includes screening of common cancers and intensive diagnosis and staging. The last phase is the treatment of the disease. Here the tumor board carries out a lot of discussions about the abnormal growth and how to deal with it. Treatment might also be offered if possible by a comprehensive cancer treatment center.

Oncortarget itself is a term that encompasses molecules, particles cellular functions common in aging and cancer. Furthermore, it also entails neurodegeneration, lymphocytes, neurons, cancer cells, and microbes. The oncortarget journal is published on a weekly basis by Impact Journals. Formed in 2010, Oncortarget is led by a team of experts highly skilled in the various roles they play. Mikhail Blagosklonny and Andrei V. Gudkov are some of the top-notch employees at Oncortarget. In fact, the two are the editors in chief of Oncortarget journal which is usually published in English. Mikhail Blagosklonny for one, is a man with great experience and expertise in the field of oncology. He holds an M.D in internal medicine and a Ph.D. in experimental medicine and cardiology from the First Pavlov State University of St. Petersberg, He is a scientist who constantly studies cancer and aging. Formerly, Mikhail Blagosklomy was a professor of oncology at the Roswell Park Cancer Institute.

Oncortarget is devoted to making scientific results widely available and within the shortest time possible. It also aims at doing away with borders between specialties and link different sectors of medical research together as one. Furthermore, Oncortarget allows different researchers from diverse biomedical fields to share their different findings and discoveries.With its ultimate goal, “Life Without Diseases,” in mind, Oncortarget hopes that the journal will constantly help researchers contribute to science and eradicate diseases. Endowed with the great scientists and medical experts, Oncortarget is slowly growing and covering other fields of health. In fact, having had massive success in the previous years, the journal has begun launching sections beyond oncology. Neuroscience, Cardiology, Cell Biology, Metabolism, and Endocrinology are some examples of these sections. Not to forget, Pharmacology, where Oncortarget covers all areas in this particular section.